CoChat

Retinoblastoma tumor suppressor protein–dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit

Open access
Blais, Alexandre, van Oevelen, Chris J.C., Margueron, Raphaël, Acosta-Alvear, Diego, Dynlacht, Brian David · 2007 · The Journal of Cell Biology

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.

Abstract

The retinoblastoma tumor suppressor protein (pRb) is involved in mitotic exit, promoting the arrest of myoblasts, and myogenic differentiation. However, it is unclear how permanent cell cycle exit is maintained in differentiated muscle. Using RNA interference, expression profiling, and chromatin immunoprecipitations, we show that pRb is essential for cell cycle exit and the differentiation of myoblasts and is also uniquely required to maintain this arrest in myotubes. Remarkably, we also uncover a function for the pRb-related proteins p107 and p130 as enforcers of a G2/M phase checkpoint that prevents progression into mitosis in cells that have lost pRb. We further demonstrate that pRb effects permanent cell cycle exit in part by maintaining trimethylation of histone H3 lysine 27 (H3K27) on cell cycle genes. H3K27 trimethylation silences other genes, including Cyclin D1, in a pRb-independent but polycomb-dependent manner. Thus, our data distinguish two distinct chromatin-based regulatory mechanisms that lead to terminal differentiation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.200705051

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. pRb depletion leads to cell cycle reentry in terminally differentiated muscle cells. (A) RT-PCR detection of pocket protein mRNA expression 48 h after transfection of C2C12 myotubes with siRNA duplexes. (B) Western blot detection of each pocket protein indicates the extent of knockdown achieved in a typical experiment. (C) Immunofluorescent detection of BrdU incorporation (green) and MHC expression (red) in differentiated C2C12 myotubes after transfection with a nonspecific siRNA duplex or duplexes targeting various pocket protein combinations. (D) Histogram representing the proportion of C2C12 myotubes with at least one BrdU+ nucleus after transfection with the indicated siRNA. Error bars indicate SD of three independent experiments. (E) Immunofluorescent detection of BrdU incorporation (red) and MHC expression (green) in primary myotubes after transfection with a nonspecific siRNA duplex or a duplex targeting pRb. Bars, 100 μm.
Figure 1. pRb depletion leads to cell cycle reentry in terminally differentiated muscle cells. (A) RT-PCR detection of pocket protein mRNA expression 48 h after transfection of C2C12 myotubes with siRNA duplexes. (B) Western blot detection of each pocket protein indicates the extent of knockdown achieved in a typical experiment. (C) Immunofluorescent detection of BrdU incorporation (green) and MHC expression (red) in differentiated C2C12 myotubes after transfection with a nonspecific siRNA duplex or duplexes targeting various pocket protein combinations. (D) Histogram representing the proportion of C2C12 myotubes with at least one BrdU+ nucleus after transfection with the indicated siRNA. Error bars indicate SD of three independent experiments. (E) Immunofluorescent detection of BrdU incorporation (red) and MHC expression (green) in primary myotubes after transfection with a nonspecific siRNA duplex or a duplex targeting pRb. Bars, 100 μm.CC BY-NC-SA · PubMed Central
Figure 2. Loss of pRb leads to derepression of cell cycle control genes. (A) RT-PCR detection of pocket protein, cell cycle, and muscle function gene expression 48 h after suppression of pocket protein expression in C2C12 myotubes. (B) Scatter plot representing the change in gene expression in C2C12 myotubes upon knockdown of pRb as a function of the gene expression changes during the normal course of myogenic differentiation. Each spot represents one measurement with one microarray probe. MT, untransfected myotubes; GM, untransfected growing myoblasts; NS, myotubes transfected with a nonspecific siRNA duplex; pRb, myotubes transfected with the pRb-specific duplex. All data points represent the combination of three independent experiments. (C) Scatter plot representing the change in gene expression in myotubes after pRb knockdown as a function of the degree of binding of E2F4 in a ChIP-on-chip microarray experiment performed in C2C12 myotubes. The binding ratio serves as an indirect measure of the strength of binding of E2F4 to its target genes; a cut-off corresponding to a twofold enrichment was used.
Figure 2. Loss of pRb leads to derepression of cell cycle control genes. (A) RT-PCR detection of pocket protein, cell cycle, and muscle function gene expression 48 h after suppression of pocket protein expression in C2C12 myotubes. (B) Scatter plot representing the change in gene expression in C2C12 myotubes upon knockdown of pRb as a function of the gene expression changes during the normal course of myogenic differentiation. Each spot represents one measurement with one microarray probe. MT, untransfected myotubes; GM, untransfected growing myoblasts; NS, myotubes transfected with a nonspecific siRNA duplex; pRb, myotubes transfected with the pRb-specific duplex. All data points represent the combination of three independent experiments. (C) Scatter plot representing the change in gene expression in myotubes after pRb knockdown as a function of the degree of binding of E2F4 in a ChIP-on-chip microarray experiment performed in C2C12 myotubes. The binding ratio serves as an indirect measure of the strength of binding of E2F4 to its target genes; a cut-off corresponding to a twofold enrichment was used.CC BY-NC-SA · PubMed Central
Figure 3. H3K27 trimethylation of cell cycle gene promoters during myogenic differentiation. (A) qChIP on chromatin from either C2C12 myoblasts or myotubes using antibodies that recognize H3K27Me2/3, H3K9Me3, and H3Ac. A scatter plot indicates the fraction of input DNA immunoprecipitated from each state. Values obtained with the H3Ac antibody were divided by 10 to fit on the same plot as the other two datasets. Results represent the mean of at least three independent experiments. (B) Histogram representing the H3K27Me3 signal from A. The Hoxa5 and Mef2c genes served as specificity controls. Error bars indicate SD of three independent experiments. (C) ChIP assay performed in C2C12 myoblasts and myotubes using antibodies against histone H3, H3K27Me2 or H3K27Me3, or rabbit IgG. (D) ChIP assay performed on cells at different times after induction of differentiation. The 96-h Mt sample represents pure myotubes, whereas the samples labeled 96 h and earlier time points represent the mixed cell population before separation of myotubes from reserve cells. (E) Quantitative ChIP assays for H3K27Me2/3 performed in primary myoblasts and matched myotubes. The mean of four ChIP assays and standard errors are shown. The ratio of H3K27Me2/3 signal in myotubes over that in myoblasts is indicated in red below each gene name. Asterisks indicate an H3K27Me2/3 signal significantly higher in myotubes than in myoblasts; P < 0.03 by t test. The double asterisk indicates an H3K27Me2/3 signal significantly lower in myotubes than in myoblasts; P < 0.001 by t test.
Figure 3. H3K27 trimethylation of cell cycle gene promoters during myogenic differentiation. (A) qChIP on chromatin from either C2C12 myoblasts or myotubes using antibodies that recognize H3K27Me2/3, H3K9Me3, and H3Ac. A scatter plot indicates the fraction of input DNA immunoprecipitated from each state. Values obtained with the H3Ac antibody were divided by 10 to fit on the same plot as the other two datasets. Results represent the mean of at least three independent experiments. (B) Histogram representing the H3K27Me3 signal from A. The Hoxa5 and Mef2c genes served as specificity controls. Error bars indicate SD of three independent experiments. (C) ChIP assay performed in C2C12 myoblasts and myotubes using antibodies against histone H3, H3K27Me2 or H3K27Me3, or rabbit IgG. (D) ChIP assay performed on cells at different times after induction of differentiation. The 96-h Mt sample represents pure myotubes, whereas the samples labeled 96 h and earlier time points represent the mixed cell population before separation of myotubes from reserve cells. (E) Quantitative ChIP assays for H3K27Me2/3 performed in primary myoblasts and matched myotubes. The mean of four ChIP assays and standard errors are shown. The ratio of H3K27Me2/3 signal in myotubes over that in myoblasts is indicated in red below each gene name. Asterisks indicate an H3K27Me2/3 signal significantly higher in myotubes than in myoblasts; P < 0.03 by t test. The double asterisk indicates an H3K27Me2/3 signal significantly lower in myotubes than in myoblasts; P < 0.001 by t test.CC BY-NC-SA · PubMed Central
Figure 4. Trimethylation of H3K27 is insensitive to mitogenic stimulation and does not occur during reversible, mitogen starvation–induced quiescence. (A) RT-PCR assay of gene expression in C2C12 myoblasts and myotubes or myotubes treated with high serum concentrations for 24 h (Mt + GM). (B) ChIP assay performed on samples from cells analyzed in A. The input control corresponds to 0.4% of the amount used per immunoprecipitation. The Hoxa5 gene is shown as a control for efficiency of immunoprecipitation by the anti-H3K9Me3 antibody. (C) MEFs were harvested during asynchronous growth or after 3 d of starvation in serum-free medium. RNA was extracted and cell cycle gene expression was assessed by RT-PCR. (D) ChIP assays performed on cross-linked cells treated and processed in parallel with those indicated in C.
Figure 4. Trimethylation of H3K27 is insensitive to mitogenic stimulation and does not occur during reversible, mitogen starvation–induced quiescence. (A) RT-PCR assay of gene expression in C2C12 myoblasts and myotubes or myotubes treated with high serum concentrations for 24 h (Mt + GM). (B) ChIP assay performed on samples from cells analyzed in A. The input control corresponds to 0.4% of the amount used per immunoprecipitation. The Hoxa5 gene is shown as a control for efficiency of immunoprecipitation by the anti-H3K9Me3 antibody. (C) MEFs were harvested during asynchronous growth or after 3 d of starvation in serum-free medium. RNA was extracted and cell cycle gene expression was assessed by RT-PCR. (D) ChIP assays performed on cross-linked cells treated and processed in parallel with those indicated in C.CC BY-NC-SA · PubMed Central
Figure 5. pRb-dependent trimethylation of H3K27 at cell cycle gene promoters. (A) Histogram indicating H3K27Me2/3 levels in C2C12 myotubes transfected with a nonspecific control or pRb-silencing siRNA. The ChIP signal intensity is reported as a fraction of the signal obtained in cells transfected with the nonspecific siRNA. (B and C) Histograms depicting H3K27Me2/3 (B) and H3Ac (C) levels in C2C12 myotubes transfected with siRNAs targeting p130 or pRb or with a nonspecific control siRNA as indicated in A. Error bars represent SD of three independent experiments. (D) ChIP assay performed in C2C12 myoblasts and myotubes using antibodies directed against Suz12, Ezh2, and Bmi-1. Two regions of the Hoxd10 gene were surveyed to evaluate PRC binding. The results of two independent experiments are shown.
Figure 5. pRb-dependent trimethylation of H3K27 at cell cycle gene promoters. (A) Histogram indicating H3K27Me2/3 levels in C2C12 myotubes transfected with a nonspecific control or pRb-silencing siRNA. The ChIP signal intensity is reported as a fraction of the signal obtained in cells transfected with the nonspecific siRNA. (B and C) Histograms depicting H3K27Me2/3 (B) and H3Ac (C) levels in C2C12 myotubes transfected with siRNAs targeting p130 or pRb or with a nonspecific control siRNA as indicated in A. Error bars represent SD of three independent experiments. (D) ChIP assay performed in C2C12 myoblasts and myotubes using antibodies directed against Suz12, Ezh2, and Bmi-1. Two regions of the Hoxd10 gene were surveyed to evaluate PRC binding. The results of two independent experiments are shown.CC BY-NC-SA · PubMed Central
Figure 6. Model detailing pRb function in differentiated muscle. See text for details.
Figure 6. Model detailing pRb function in differentiated muscle. See text for details.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 69 references

Research works printed but not linked: 5

  1. 2002, Cell Cycle., 1, 103
  2. 1995, Oncogene., 11, 801
  3. 1996, J. Cell. Biochem., 62, 418, 10.1002/(SICI)1097-4644(199609)62:3<418::AID-JCB12>3.0.CO;2-E · DOI
  4. 2004, Methods Enzymol., 376, 255
  5. 1996, Oncogene., 13, 1511

Cited by

See all 126

Metadata

Authors
Blais, A., van Oevelen, C. J. C., Margueron, R., Acosta-Alvear, D., & Dynlacht, B. D.
Affiliations
  • University of Ottawa (CA)
  • 2Department of Pathology, New York University Cancer Institute
  • 3Department of Biochemistry, New York University School of Medicine, New York, NY 10016
  • New York University (US)
Corresponding author
Blais, Alexandre
Venue
The Journal of Cell Biology
Published
2007-12-31
Volume
179
Issue
7
Pages
1399-1412
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2026185344
Cited by
126
References
69
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 9 · 2016: 9 · 2015: 9 · 2014: 9 · 2013: 8 · 2012: 5
FWCI
3.45
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Cell Biology (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • National Cancer Institute (R01CA077245, CA77245)
  • National Institute of General Medical Sciences (R01GM067132, GM067132)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
retinoblastoma protein, H3K27me3, cell cycle exit, myogenesis, myotubes, p107, p130, G2/M checkpoint, Polycomb, cyclin D1, terminal differentiation, chromatin regulation
MeSH terms
Animals, Cell Cycle, Cell Differentiation, Cell Division, Cell Line, Histones, Lysine, Retinoblastoma Protein, G2 Phase, Cell Cycle Proteins, Genes, cdc, DNA Methylation, Gene Silencing, Gene Expression Profiling, Myoblasts, Skeletal, RNA Interference, Retinoblastoma-Like Protein p130, Retinoblastoma-Like Protein p107, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retinoblastoma tumor suppressor protein–dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. https://app.cochat.ai/papers/10.1083/jcb.200705051
The paper
Blais, A., van Oevelen, C. J. C., Margueron, R., Acosta-Alvear, D., & Dynlacht, B. D. (2007). Retinoblastoma tumor suppressor protein–dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit. The Journal of Cell Biology. https://doi.org/10.1083/jcb.200705051

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.